Clinical trials: Insulin Pump Therapy
Diabetes
Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults
The purpose of this study is to compare the in-line fluid pressure (pressure of the fluid going through the tubing) and leakage (observation of fluid on and around the device) during and after subcutaneous infusion using two…
- Trial name
- NCT02382536
- Testing
- BD Scarlett Infusion set, Medtronic QuickSet Infusion Set
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Becton, Dickinson and Company
Type 2 Diabetes
Pilot Study Assessing Insulin Pump Therapy in Type 2 Diabetes
16-week, open-label, multi-center pilot study. Insulin pump naïve subjects with type 2 diabetes who are not achieving glycemic targets (screening A1C ≥ 7.0%) on an established regimen of either: 1) ≥ 2 OAs (Cohort A), 2) basal…
- Trial name
- NCT00922649
- Testing
- Insulin Pump therapy
- Where
- 6 sites in United States
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Animas Corporation
Type 2 Diabetes Mellitus
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
This study aims at describing the glucose level by automated glucose sensors and correlating it with insulin delivery and meals over 14 days in insulin-requiring T2D patients living in real-life conditions.
- Trial name
- CLOSE (NCT03436212)
- Testing
- Continuous Glucose Monitoring (CGM)
- Where
- France
- Volunteers
- 24 people
- Sponsor
- Air Liquide Santé International
Type 1 Diabetes Mellitus
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
This study is testing VV-14299 and VV-14300 or VV-14300 alone in adults with long-standing type 1 diabetes (T1D) whose blood sugar is not well controlled despite using an automated insulin delivery (AID) system.
- Trial name
- PROGRESS (NCT07829302)
- Testing
- VV-14300, VV-14299
- Where
- Australia
- Volunteers
- 29 people
- Sponsor
- Kriya Therapeutics, Inc.